Medifast, Inc. (MED) Misses Q3 EPS by 1c, Sales Fall Short
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $10.73 -2.63%
Revenue Growth %: -29.3%
Financial Fact:
Diluted earnings per share: 0.51
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -29.3%
Financial Fact:
Diluted earnings per share: 0.51
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q3 EPS of $0.36, $0.01 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $76.1 million versus the consensus estimate of $78.89 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
- Safe Bulkers (SB) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
